Characterising properties of dimethylfumarate on innate and adaptive immunity: longitudinal data from MS patients

MULTIPLE SCLEROSIS JOURNAL

SAGE PUBLICATIONS LTD

1. Biogen
2. Novartis Pharma
3. Merck Serono
4. Teva
5. Bayer-Schering
6. GeNeuro
7. Mitsubishi Pharma
8. MedDay
9. Roche
10. Genzyme
11. Swiss MS Society
12. Swiss National Science Foundation
13. European FP6 program
14. IMI JU program
15. Roche Postdoc Fellowship Program (RPF-program)
16. Novartis
17. Actelion
18. Addex
19. Bayer HealthCare
20. Biotica
21. Lilly
22. Merck
23. Mitsubishi
24. Ono
25. Pfizer
26. Receptos
27. Sanofi-Aventis
28. Santhera
29. Siemens
30. UCB
31. Xenoport
32. CSL Behring
33. European Union
34. Roche Research Foundations
35. Swiss Multiple Sclerosis Society
36. Swiss National Research Foundation